Research Options:
Week of Expected Pricing Withdrawn
Company Name Iroko pharmaceuticals Inc.
Proposed Ticker IRKO
CUSIP G49497103
Business Description A global, specialty pharmaceutical company focused on the development and commercialization of novel nonsteroidal anti-inflammatory drug, or NSAID,therapeutics for patients with mild to moderate acute and chronic pain.
Lead Underwriter Jefferies LLC, William Blair and Co., L.L.C.
Co-Managers Canaccord Genuity Inc., Oppenheimer and Co., Inc.
Initial Shares 6,500,000
Revised Initial Shares N/A
Initial Price $14.00-$17.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.